Clinical Analysis of High-Risk Primary and Metastatic Breast Cancer Patients with Neutropenia and Fever after High-Dose Chemotherapy

JIANG Han-fang,DI Li-jun,SONG Guo-hong,YU Jing,ZHU Yu-lin,WANG Xiao-li,JIA Jun,CHE Li,REN Jun

DOI: https://doi.org/10.16073/j.cnki.cjcpt.2010.24.013

2010-01-01

Abstract:OBJECTIVE:To explore the incidence of febrile neutropenia(FN),infection,major pathogens,and treatment measures for high-risk primary and metastatic breast cancer patients after high-dose chemotherapy.METHODS:Totally 145 cases of high-dose chemotherapy in high-risk primary and metastatic breast cancer patients from July 2004 to April 2009 were reviewed and analyzed their clinical data was analyzed.RESULTS:The incidence of neutropenia in high-risk primary and metastatic breast cancer patients after high-dose chemotherapy was 97.2%(141/145).The incidence of FN was 57.2%(83/145),and the duration of fever was(3.37±1.77) days.The median low nadir of ANC was 0.000×109 L-1 and 0.026×109 L-1 in the fever and normal groups,respectively(χ2=4.563,P=0.033),with the mean duration of neutropenia of 4.75 days vs.3.26 days(t=4.409,P=0.000).There were 8.4%(7/83) microbiologically documented infections,56.6%(47/83) clinically suspected infections and 34.9%(29/83) FUO.The most common focus of infection was the pharynx,mouth and tongue(28.9%) followed by the gastrointestinal tract(24.1%).Gram-negative microorganisms were the most frequently isolated agents(42.9%).The overall response rate to empirical antibiotherapy was 100.0%.CONCLUSIONS:There are very high incidences of neutropenia and FN in high-risk primary and metastatic breast cancer patients receiving high-dose chemotherapy,frequently occur in a week for 3 to 4 days.Digestive tract is the common sites of infection,and gram-negative bacteria are the main pathogens.Comprehensive treatment measures are effective.